The field of metagenomics has allowed researchers to delve into the diversity of the body’s microbiota with findings that the microbiome is a home for diversity, natural immunity, metabolism, behavioural traits, and plays an instrumental role in health and disease. With large-scale collaborative projects underway and sequencing data placed in the public domain, there is a rich source of information for researchers and companies looking for opportunities in this exciting field. With increasing signs that our microbiome may be the key not only for curative but preventative medicine, efforts are focusing on increasing both investment opportunities, clinical trials and innovative research in this area. With an increasing focus on healthy living and a therapeutics market that is expected to grow to $1.2 trillion by 2016, microbial research can be developed in order to provide preventative treatments, cures, therapies and supplements for a worldwide audience in demand.